|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Package code:
|
1390777
|
|
Name of medicinal product:
|
Masivet
|
|
Active substances:
|
|
|
ATC code:
|
QL01EX06
|
|
Dosage form:
|
film-coated tablet
|
|
Route of administration:
|
oral use
|
|
Strengh:
|
50mg
|
|
Amount in package:
|
30TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
Treatment of non-resectable dog mast cell tumours (Grade 2 or 3) with confirmed mutated c-kit
tyrosine kinase receptor.
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Withdrawal time:
|
Ei rakendata.
|
|
Species:
|
koer
|
|
Last imported to Estonia:
|
16 March 2021
|
|
Marketing authorization holder:
|
AB Science
|
|
Marketing authorization number:
|
EU/2/08/087
|
|
Marketing authorization issued on:
|
17 November 2008
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
Entry/Changing date:
19 November 2013
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription